QT
IOVA icon

Quantamental Technologies’s Iovance Biotherapeutics IOVA Stock Holding History

Quantamental Technologies’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-40,384
Closed -$284K – 439
2023
Q2 		$284K Buy
40,384
+25,808
+177% +$185K 0.12% 297
2023
Q1 		$89.1K Buy
+14,576
New +$101K 0.05% 383
2022
Q4 		– Sell
-15,833
Closed -$152K – 556
2022
Q3 		$152K Buy
15,833
+1,100
+7% +$12.7K 0.06% 439
2022
Q2 		$163K Buy
+14,733
New +$193K 0.07% 364
2019
Q4 		– Sell
-5,803
Closed -$106K – 864
2019
Q3 		$106K Buy
+5,803
New +$128K 0.03% 724

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantamental Technologies's IOVA Position: Q3 2023 in Review

Quantamental Technologies sold out of Iovance Biotherapeutics (IOVA) in Q3 2023, closing a stake of 40,384 shares — an estimated $284K sold.

Quantamental Technologies first reported a position in IOVA in Q3 2019 and held it in 5 quarters. The position peaked at $284K in Q2 2023. 227 funds tracked by Wall St. Rank hold IOVA as of Q3 2023.

  • Quantamental Technologies reported no remaining Iovance Biotherapeutics position as of Q3 2023 after selling out during the quarter.
  • Quantamental Technologies sold 40,384 Iovance Biotherapeutics shares in Q3 2023, an estimated $284K.
  • Quantamental Technologies first reported a position in Iovance Biotherapeutics in Q3 2019 and held it in 5 quarters.
  • Quantamental Technologies's Iovance Biotherapeutics position peaked at $284K in Q2 2023.
  • 227 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.